Published in J Antimicrob Chemother on July 01, 1999
Treatment outcomes for Mycobacterium avium complex: a systematic review and meta-analysis. Eur J Clin Microbiol Infect Dis (2013) 0.95
Sublethal concentrations of the aminoglycoside amikacin interfere with cell division without affecting chromosome dynamics. Antimicrob Agents Chemother (2006) 0.85
Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial. Lancet (1999) 4.68
Mild hyperlactatemia in stable septic patients is due to impaired lactate clearance rather than overproduction. Am J Respir Crit Care Med (1998) 1.80
Brucellosis from sniffing bacteriological cultures. Lancet (1997) 1.70
Surgical treatment of the boxer's fracture: transverse pinning versus intramedullary pinning. J Hand Surg Eur Vol (2007) 1.57
The dynamic of adherence to highly active antiretroviral therapy: results from the French National APROCO cohort. J Acquir Immune Defic Syndr (2001) 1.51
Gradient plate method to induce Streptococcus pyogenes resistance. J Antimicrob Chemother (1999) 1.50
Atypical cutaneous histological features of visceral leishmaniasis in acquired immunodeficiency syndrome. Am J Dermatopathol (1995) 1.44
Prolonged low-dose dopamine infusion induces a transient improvement in renal function in hemodynamically stable, critically ill patients: a single-blind, prospective, controlled study. Crit Care Med (2000) 1.41
Comparison of the renal effects of low to high doses of dopamine and dobutamine in critically ill patients: a single-blind randomized study. Crit Care Med (2000) 1.41
[Prognosis of acute tuberculous respiratory distress syndrome. 4 cases]. Presse Med (1995) 1.39
[Aspergillus fumigatus muscle abscess revealing invasive aspergillosis in a patient with AIDS]. Presse Med (1998) 1.38
Determination of optimal dosage regimen for amikacin in healthy volunteers by study of pharmacokinetics and bactericidal activity. Antimicrob Agents Chemother (1990) 1.35
A large French prospective cohort of HIV-infected patients: the Nadis Cohort. HIV Med (2009) 1.29
Multicenter evaluation of the new Abbott RealTime assays for quantitative detection of human immunodeficiency virus type 1 and hepatitis C virus RNA. J Clin Microbiol (2007) 1.28
Persisting long-term benefit of genotype-guided treatment for HIV-infected patients failing HAART. The Viradapt Study: week 48 follow-up. Antivir Ther (2000) 1.24
Risk of invasive cervical cancer among women with, or at risk for, HIV infection. Int J Cancer (1999) 1.20
A canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated CMV vaccine (Towne). J Infect Dis (1999) 1.12
In vitro selection of mutants of Streptococcus pneumoniae resistant to macrolides and linezolid: relationship with susceptibility to penicillin G or macrolides. J Antimicrob Chemother (2005) 1.10
Epidemiology of bacterial infection during management of open leg fractures. Eur J Clin Microbiol Infect Dis (1999) 1.08
In the era of highly active antiretroviral therapy, why are HIV-infected patients still admitted to hospital for an inaugural opportunistic infection? HIV Med (2005) 1.07
Highly active antiretroviral treatment does not increase sexual risk behaviour among French HIV infected injecting drug users. J Epidemiol Community Health (2002) 1.07
A study of nineteen immunocompromised patients with extensive skin lesions caused by Pseudomonas aeruginosa with and without bacteremia. Acta Derm Venereol (1991) 1.06
Effects of subinhibitory concentrations of vancomycin and teicoplanin on adherence of staphylococci to tissue culture plates. Antimicrob Agents Chemother (1993) 1.05
Long-term (96-week) follow-up of antiretroviral-naïve HIV-infected patients treated with first-line lopinavir/ritonavir monotherapy in the MONARK trial. HIV Med (2009) 1.05
Overexpression of Fas/CD95 and Fas-induced apoptosis in a patient with idiopathic CD4+ T lymphocytopenia. Clin Infect Dis (1999) 1.04
Cutaneous leishmaniasis due to Leishmania infantum. Case reports and literature review. Arch Dermatol (1998) 1.04
Impact of highly active antiretroviral therapy on the incidence of visceral leishmaniasis in a French cohort of patients infected with human immunodeficiency virus. J Infect Dis (2002) 1.03
Synergistic activation of the N-methyl-D-aspartate receptor subunit 1 promoter by myocyte enhancer factor 2C and Sp1. J Biol Chem (1998) 1.03
Efficacy of subinhibitory concentration of pefloxacin in preventing experimental Staphylococcus aureus foreign body infection in mice. Drugs Exp Clin Res (1992) 1.00
Allopurinol for treatment of visceral leishmaniasis in patients with AIDS. J Infect Dis (1989) 0.98
Pneumococcal resistance patterns in Europe. Eur J Clin Microbiol Infect Dis (1997) 0.98
Evaluating counseling outcome on adherence to prophylaxis and follow-up after sexual HIV-risk exposure: a randomized controlled trial. AIDS Care (2010) 0.97
Antibiotic misuse: a prospective clinical audit in a French university hospital. Eur J Clin Microbiol Infect Dis (2007) 0.97
Coracoid bone block versus arthroscopic Bankart repair: a comparative paired study with 5-year follow-up. Orthop Traumatol Surg Res (2013) 0.97
Glycolysis inhibition targets Mcl-1 to restore sensitivity of lymphoma cells to ABT-737-induced apoptosis. Leukemia (2011) 0.96
Clinical efficacy of monotherapy with stavudine compared with zidovudine in HIV-infected, zidovudine-experienced patients. A randomized, double-blind, controlled trial. Bristol-Myers Squibb Stavudine/019 Study Group. Ann Intern Med (1997) 0.96
Prevalence of antibody to hepatitis C virus (HCV) in HIV-1-infected patients (nice SEROCO cohort). J Med Virol (1994) 0.96
HIV resistance to antiretroviral drugs: mechanisms, genotypic and phenotypic resistance testing in clinical practice. Acta Clin Belg (2002) 0.95
Incidence and risk factors of bacterial pneumonia requiring hospitalization in HIV-infected patients started on a protease inhibitor-containing regimen. HIV Med (2006) 0.94
Small animal PET scanner based on monolithic LYSO crystals: performance evaluation. Med Phys (2012) 0.93
Highly active anti-retroviral therapy (HAART) is associated with a lower level of CD4+ T cell apoptosis in HIV-infected patients. Clin Exp Immunol (1999) 0.93
Use of buprenorphine in HIV-infected injection drug users: negligible impact on virologic response to HAART. The Manif-2000 Study Group. Drug Alcohol Depend (2000) 0.92
Application of Bayesian estimation for the prediction of an appropriate dosage regimen of amikacin. J Pharm Sci (1989) 0.92
Adverse effects of parenteral antimicrobial therapy for chronic bone infections. Eur J Clin Microbiol Infect Dis (2008) 0.91
Design and evaluation of the MAMMI dedicated breast PET. Med Phys (2012) 0.91
Iatrogenic Cushing's syndrome in an HIV-infected patient treated with inhaled corticosteroids (fluticasone propionate) and low dose ritonavir enhanced PI containing regimen. J Infect (2002) 0.90
The diffusion of pefloxacin into bone and the treatment of osteomyelitis. J Antimicrob Chemother (1986) 0.90
GAPDH binds to active Akt, leading to Bcl-xL increase and escape from caspase-independent cell death. Cell Death Differ (2013) 0.88
Impact of short-term adherence on virological and immunological success of HAART: a case study among French HIV-infected IDUs. Int J STD AIDS (2001) 0.88
Differences in HIV testing, knowledge and attitudes in pregnant women who deliver and those who terminate: Prevagest 1992--France. AIDS Care (1995) 0.88
Diarrhea and Campylobacter infections in patients infected with the human immunodeficiency virus. J Infect Dis (1989) 0.87
In-vitro development of resistance to beta-lactam antibiotics in Streptococcus pneumoniae. J Antimicrob Chemother (1995) 0.87
[Bacterial resistance and antibiotic prescriptions: perceptions, attitudes and knowledge of a sample of French GPs]. Med Mal Infect (2010) 0.87
[Effects of rifampicin on the pharmacokinetics of doxycycline]. Pathol Biol (Paris) (1987) 0.87
Intracellular concentration of protease inhibitors in HIV-1-infected patients: correlation with MDR-1 gene expression and low dose of ritonavir. HIV Clin Trials (2002) 0.87
[Senegal and malaria. True prophylactic failure of mefloquine]. Presse Med (2002) 0.87
Intestinal and extraintestinal Isospora belli infection in an AIDS patient. A second case report. Pathol Res Pract (1994) 0.86
[Hospital medical students: a population at risk for accidental exposure to blood]. Presse Med (1998) 0.86
[Discriminant factors of the risk of infection in routine digestive surgery. Trial apropos of 308 cases]. Ann Chir (1982) 0.86
Factors related to the prescription of antibiotics for young children with viral pharyngitis by general practitioners and paediatricians in southeastern France. Eur J Clin Microbiol Infect Dis (1999) 0.86
[Secondary Streptococcus pyogenes peritonitis following necrotizing fasciitis]. Ann Fr Anesth Reanim (2004) 0.85
[Motives for the prescription of antibiotics in the emergency department of the University Hospital Center in Nice. A prospective study]. Presse Med (2002) 0.85
[Adherence properties and production of slime by staphylococci: relation to pathogenicity]. Pathol Biol (Paris) (1990) 0.85
Mycobacterial cutaneous manifestations: a new sign of immune restoration syndrome in patients with acquired immunodeficiency syndrome. Arch Dermatol (1999) 0.85
Skin manifestations of West Nile virus infection. Dermatology (2005) 0.84
Outbreak of typhoid fever on the French Riviera. Eur J Clin Microbiol Infect Dis (2000) 0.84
[A case of external ophthalmomyiasis by Oestrus ovis, Linné, 1758 caught on the Nice beach (author's transl)]. Acta Trop (1981) 0.84
[Extension reserve of the hip in relation to the spine: Comparative study of two radiographic methods]. Rev Chir Orthop Reparatrice Appar Mot (2008) 0.83
Six weeks antibiotic therapy for all bone infections: results of a cohort study. Eur J Clin Microbiol Infect Dis (2009) 0.83
Efficacy, safety and predictive factors of virological success of a boosted amprenavir-based salvage regimen in heavily antiretroviral-experienced HIV-1-infected patients. HIV Med (2004) 0.83
[Secondary infection of joint implants: diagnostic criteria, treatment and prevention]. Rev Chir Orthop Reparatrice Appar Mot (2002) 0.83
Economic evaluation of drug resistance genotyping for the adaptation of treatment in HIV-infected patients in the VIRADAPT study. J Acquir Immune Defic Syndr (2000) 0.83
Atypical leishmaniasis in a patient infected with human immunodeficiency virus. Clin Infect Dis (1995) 0.83
[Tuberculosis discovered in a patient with Sweet's syndrome]. Presse Med (2001) 0.83
Acute renal failure as initial presentation of visceral leishmaniasis in an HIV-1-infected patient. Scand J Infect Dis (2002) 0.83
[Muscular involvement in the course of AIDS. Anatomo-clinical study of 17 cases]. Ann Pathol (1995) 0.82
Increased time exposure to tenofovir is associated with a greater decrease in estimated glomerular filtration rate in HIV patients with kidney function of less than 60 ml/min/1.73 m2. Nephron Clin Pract (2012) 0.82
Botulism and hot-smoked whitefish: a family cluster of type E botulism in France, September 2009. Euro Surveill (2009) 0.82
Unusual cutaneous manifestations of miliary tuberculosis. Clin Infect Dis (2000) 0.82